Poland · Research
Research
Pharmaceuticals
Biotechnology
Animal Health
Bioceltix S.A. is a biotechnology company based in Wroclaw, Poland, founded in 2018. The company specializes in developing stem cell-based biopharmaceuticals for veterinary medicine, focusing on advanced therapies for companion animals and horses. With a team of 28 employees, Bioceltix operates within the healthcare sector, emphasizing regenerative medicine. The company's product pipeline includes BCX-CM-J, a biological drug for treating degenerative joint lesions in dogs; BCX-CM-AD, aimed at managing atopic dermatitis in dogs; and BCX-EM, a therapy for equine arthritis. Bioceltix utilizes allogeneic mesenchymal stem cell technology, which allows for standardized treatments that can be readily available for veterinary clinics and pet owners. The company is dedicated to enhancing veterinary care through clinically validated and scalable biopharmaceuticals.
2017
Founded
Research
Industry
Poland
Location
12,414,624
Ranking
32 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
